Robert I. Blum - 04 Jan 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
President & CEO, Director
Signature
/s/ John Faurescu, attorney-in-fact for Mr. Blum
Issuer symbol
CYTK
Transactions as of
04 Jan 2023
Transactions value $
-$345,900
Form type
4
Filing time
06 Jan 2023, 15:06:18 UTC
Previous filing
03 Jan 2023
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $96.5K +10K +2.46% $9.65 416K 04 Jan 2023 Direct F1
transaction CYTK Common Stock Sale -$442K -10K -2.4% $44.24 406K 04 Jan 2023 Direct F1
holding CYTK Common Stock 2.08K 04 Jan 2023 by Trust 1 F2
holding CYTK Common Stock 2.08K 04 Jan 2023 by Trust 2 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10K -6.04% $0.00 156K 04 Jan 2023 Common Stock 10K $9.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.
F2 Shares held by The Bridget Blum 2003 Irrevocable Trust.
F3 Shares held by The Brittany Blum 2003 Irrevocable Trust.